Integrated Solutions for Antibody Discovery

Curia—formerly AMRI—is an end-to-end CDMO built to help pharmaceutical and biotech companies improve patients’ lives. We combine a flexible suite of R&D and manufacturing capabilities with industry-leading expertise to help our partners accelerate the journey from idea to impact. In addition to upstream hybridoma-based and display-based antibody discovery, Curia also offers downstream antibody engineering, production, cell line & process development, and GMP manufacturing.

Click on each box below to learn more.